Skip to content

Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty

Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00951951
Enrollment
64
Registered
2009-08-04
Start date
2009-06-30
Completion date
2014-12-31
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

The primary objectives of the study is to compare gait kinematics and the return to normalization of gait in patients that have undergone a Total Hip Arthroplasty (THA) via the direct anterior approach versus the posterior approach. Gait kinematics will be measured using the IDEEA LifeGait device from Minisun (Fresno, CA).

Detailed description

This is a prospective study of two different surgical approaches to THA, direct anterior vs posterior approach in approximately 64 patients that meet the standard criteria for the implantation of primary total hip replacement utilizing the Medacta implants and have elected to undergo THA.

Interventions

Anterior Minimal Invasive Surgery (AMIS)

Sponsors

Medacta International SA
CollaboratorINDUSTRY
Medacta USA
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients fulfilling the standard criteria for the implantation of primary total hip arthroplasty * Those presenting with primary or secondary osteoarthritis * Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use)

Exclusion criteria

* Pregnant women or women who plan to conceive within the year following surgery * Inflammatory arthritic condition * Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems * Those already treated with a failed Total Hip Arthroplasty (THA) * Muscle contracture around the hip joint * Individuals who have undergone organ transplant * Those with a known co-existent medical condition where death is anticipated within five years due to the pre-existing medical condition. * Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study * Individuals who have had a THA on the contra-lateral side within the 6 months. * Individuals who have undergone a THR on the contra-lateral side and whose outcome is considered unsatisfactory or not good * Individuals requiring bilateral hip replacement * Individuals whose body mass index (BMI; kg/m2) \>40 * Individuals with active or suspected infection or sepsis * Individuals with chronic renal failure as defined by the need for dialysis * Patients with severe forms of developmental dysplasia of the hip (DDH): Crowe types II, III, IV * History of drug and/or substance abuse

Design outcomes

Primary

MeasureTime frame
Compare gait kinematics and the return to normalization of gait in patients that have undergone a THA via the direct anterior approach vs. the posterior approach.Pre-Op, (2 weeks if fully ambulatory), 6 weeks, 3 months, 1 year

Secondary

MeasureTime frame
Evaluate/compare two surgical approaches (direct anterior vs. posterior): Patient improvement (subjective and objective) following THA using the HHS. Patient overall function and pain following THA using the WOMAC. Post operative radiological findingsPre-Op, 6 weeks, 3 months, 1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026